Compare Dow Jones Industrial Average ETF (DIA) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dow Jones Industrial Average ETF vs GeneDx Holdings Corp — how do they compare? Dow Jones Industrial Average ETF trades at $516.07 (market cap $45.20B), while GeneDx Holdings Corp trades at $67.33 (market cap $2.02B). The key difference: Dow Jones Industrial Average ETF is far larger — about 22.4× GeneDx Holdings Corp's market cap, and Dow Jones Industrial Average ETF is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Dow Jones Industrial Average ETF for 104 Days and GeneDx Holdings Corp for 19 Days on average.
| DIA | WGS | |
|---|---|---|
Market Cap | $45.20B | $2.02B |
Volume | 4,095,368 | 734,640 |
52-Week High | $542.79 | $167.51 |
52-Week Low | $451.37 | $34.51 |
Typical Hold Time | 104 Days | 19 Days |
Sector | — | Health |
Enterprise Value | — | $2.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DIA (SPDR Dow Jones Industrial Average ETF Trust) trades at $516.07, up 0.99% with bearish technical signals from moving averages. The ETF maintains dividend distributions with three recent payouts scheduled through October 2026. Market sentiment reflects broader volatility concerns amid economic uncertainty and Fed policy speculation.
The ETF's outlook remains tied to Dow component performance, with technical resistance at $516 limiting near-term upside. Dividend consistency provides income stability, though bearish momentum and market-wide pressures pose headwinds for large-cap value exposure.
GeneDx (WGS) trades at $67.33, down 1.75% today, with a mixed technical picture showing bearish moving averages but oversold RSI readings. The company reported Q2 2026 revenue of $114.4M, beating expectations with a return to adjusted profitability, though full-year 2026 shows negative net margins. Recent news highlights product launches and positive analyst coverage with 91% buy ratings.
While analyst consensus is strongly bullish with an $81 price target, fundamental risks remain due to negative profitability and high valuation multiples. The stock offers potential upside if operational improvements continue, but investors face execution risk amid ongoing losses and competitive pressures in the genomics space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Dow Jones Industrial Average ETF
The ETF is designed to track the performance of the securities and the stocks in the Dow Jones Industrial Average Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on DIA →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
